Fisher A, Pittel Z, Haring R, Bar-Ner N, Kliger-Spatz M, Natan N, Egozi I, Sonego H, Marcovitch I and Brandeis R (2003) Ml muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy
GLP-1 SUPPORT FOR SENSITIVE STOMACHS: Specifically designed for people navigating GLP-1 lifestyle changes who need gut support without triggering more discomfort
Get to know our team below
This article examines the mechanism of GLP-1 agonists, their potential risks in Crohn's disease, practical management strategies, and alternative weight management options for patients with inflammatory bowel disease
CrossRef Obesity and Metabolic Syndrome Brown Fat and Browning for the Treatment of Obesity and Related Metabolic Disorders So Hun Kim, Jorge Plutzky Diabetes Metab J
10.1038/ng.3766 135 LiuS.ZhuB.SunY.XieX